Skip to main content
. 2020 Aug 12;25(10):1822–1838. doi: 10.1016/j.drudis.2020.08.002

Table 1.

Drug categorization based on mechanism of action

Category I: inhibit RNA-dependent RNA Pol Category II: bind ACE2 receptor and increase endosomal pH Category III: inhibit SARS-COV-2 main protease Category IV: prevent interaction of S protein with ACE2 Category V: bind IL-6R Category VI: inhibit TMPRSS2
Remdesivir, favipiravir, ribavirin HCQ, CQ Lopinavir, ritonavir (inhibits CYP450-3A4) Umifenovir Tocilizumab, sarilumab Camostat